Diabetes linked to higher Parkinson's risk

1 April 2007

People who have type 2 diabetes are more likely to develop Parkinson's disease as they age, although researchers are uncertain what accounts for the link between the two diseases, according to a new study being published in the April issue of Diabetes Care.

The study, by researchers in Finland, is the first large prospective trial to find type 2 diabetes to be a risk factor for PD, a movement disorder characterized by muscle rigidity and tremors.

According to the authors, people with type 2 diabetes are 83% more likely to be diagnosed with Parkinson's than those in the general population. The study found the association between the two diseases existed for both men and women, independently of other confounding factors.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight